Amedeo Smart

Free Medical Literature Service


 

Amedeo

Kidney Transplantation

  Free Subscription

Articles published in
J Am Soc Nephrol
    February 2026
  1. GUPTA M, Cheng XS
    Rethinking Routine Coronary Screening in Kidney Transplant Candidates.
    J Am Soc Nephrol. 2026 Feb 27. doi: 10.1681/ASN.0000001042.
    >> Share

  2. SHI B, Bleasel JM, Ying T, Chadban SJ, et al
    Design and Reporting Quality of Noninferiority Trials in Kidney Transplantation: A Systematic Review.
    J Am Soc Nephrol. 2026 Feb 25. doi: 10.1681/ASN.0000001041.
    >> Share

    December 2025
  3. CHAPMAN GB, Dhaun N
    Cardiovascular Risk Assessment in Kidney Transplantation: Are We Asking the Right Questions?
    J Am Soc Nephrol. 2025 Dec 23. doi: 10.1681/ASN.0000000987.
    >> Share

  4. CHEN G, Wang Z
    Conceptual and Methodological Considerations in Assessing Disparities after Preemptive Kidney Transplant Waitlisting.
    J Am Soc Nephrol. 2025 Dec 16. doi: 10.1681/ASN.0000000973.
    >> Share

  5. ADEYEMO S, Crews DC, Lentine KL, Al Ammary F, et al
    Authors' Reply: Conceptual and Methodological Considerations in Assessing Disparities after Preemptive Kidney Transplant Waitlisting.
    J Am Soc Nephrol. 2025 Dec 16. doi: 10.1681/ASN.0000000974.
    >> Share

  6. HUSAIN SA, Neil D, Sharif A, Naesens M, et al
    Preimplantation Histopathologic Assessment of Deceased Donor Kidneys: Recommendations from the Banff Time-Zero Biopsy Working Group.
    J Am Soc Nephrol. 2025;36:2505-2513.
    >> Share

    November 2025
  7. BRENNAN DC
    Redefining Immunosuppression in Older Kidney Transplant Recipients: Reflections on the OPTIMIZE Study.
    J Am Soc Nephrol. 2025 Nov 7. doi: 10.1681/ASN.0000000939.
    >> Share

  8. SANDERS JF, de Boer SE, Jonker J, Bemelman FJ, et al
    Immunosuppression in Older Kidney Transplant Recipients: A Randomized Controlled Trial.
    J Am Soc Nephrol. 2025 Nov 7. doi: 10.1681/ASN.0000000924.
    >> Share

  9. CARDOSO DE AGUIAR R, Willicombe M, Roufosse C
    Noninvasive Diagnosis of Kidney Allograft Rejection.
    J Am Soc Nephrol. 2025;36:2269-2285.
    >> Share

  10. GOUTAUDIER V, Aubert O, Racape M, Truchot A, et al
    Detection of Kidney Allograft Rejection Using Urinary Chemokines.
    J Am Soc Nephrol. 2025;36:2228-2240.
    >> Share

    October 2025
  11. TATAPUDI VS, Mattoo A, Schiff T, Mehta SA, et al
    Xenotransplantation: Current Understanding of the Mechanism of Immune-Mediated Injury.
    J Am Soc Nephrol. 2025;36:2030-2040.
    >> Share

    September 2025
  12. ADEYEMO S, Crews DC, Lentine KL, Zisman-Ilani Y, et al
    Racial and Ethnic Disparities in Outcomes following Preemptive Kidney Transplant Waitlisting in the United States from 2009-2024.
    J Am Soc Nephrol. 2025 Sep 16. doi: 10.1681/ASN.0000000876.
    >> Share

  13. EBRAHIMI N, Wongworawat YC, Pour AA, Norouzi S, et al
    Correction to: Kidney Week 2024 Abstract Treatment of Recurrent IgA Nephropathy after Kidney Transplant with Delayed-Release Budesonide TH-PO709.
    J Am Soc Nephrol. 2025 Sep 10. doi: 10.1681/ASN.0000000892.
    >> Share

    July 2025
  14. CHRISTOU CD, Jaradat F, Olsburgh J, Sacks S, et al
    Rationale for Targeting Complement to Mitigate Renal Transplant Ischemia-Reperfusion Injury.
    J Am Soc Nephrol. 2025 Jul 22. doi: 10.1681/ASN.0000000826.
    >> Share

    May 2025
  15. PERKINS GB, Tunbridge MJ, Chai CS, Hope CM, et al
    mTOR Inhibitors and Vaccine Response in Kidney Transplant Recipients.
    J Am Soc Nephrol. 2025 May 22. doi: 10.1681/ASN.0000000716.
    >> Share

  16. SCHOLD JD, Arrigain S, Husain SA, Yu M, et al
    Variation of eGFR Wait Time Modifications for Black Kidney Transplant Candidates in the United States.
    J Am Soc Nephrol. 2025 May 6. doi: 10.1681/ASN.0000000734.
    >> Share

  17. JAVA A, Sparks MA, Kavanagh D
    Post-transplant Thrombotic Microangiopathy.
    J Am Soc Nephrol. 2025;36:940-951.
    >> Share

    April 2025
  18. VINSON AJ, Matas A
    Late Allograft Loss and Contemporary Cardiorenal Metabolic Therapies.
    J Am Soc Nephrol. 2025;36:1659-1667.
    >> Share

  19. TRUCHOT A, Raynaud M, Helantera I, Aubert O, et al
    Competing and Noncompeting Risk Models for Predicting Kidney Allograft Failure.
    J Am Soc Nephrol. 2025;36:688-701.
    >> Share

    March 2025
  20. TELLEZ GARCIA JM, Steenvoorden T, Bemelman F, Hilhorst M, et al
    The Purinoreceptor P2X7 in Extracellular ATP-Mediated Inflammation through the Spectrum of Kidney Diseases and Kidney Transplantation.
    J Am Soc Nephrol. 2025 Mar 28. doi: 10.1681/ASN.0000000711.
    >> Share

    February 2025
  21. ADLER JT, Kuk AE, Drewry KM, Nguyen KH, et al
    Implications of Increased Medicare Advantage Enrollment for Access to Kidney Transplant Waitlisting.
    J Am Soc Nephrol. 2025 Feb 20. doi: 10.1681/ASN.0000000667.
    >> Share

    November 2024
  22. TANGIRALA N, Hewawasam E, Davies CE, Poprzeczny A, et al
    Labor and Delivery Outcomes in Australian Mothers after Kidney Transplantation.
    J Am Soc Nephrol. 2024 Nov 25. doi: 10.1681/ASN.0000000559.
    >> Share

    October 2024
  23. HELLE F, Aubry A, Morel V, Descamps V, et al
    Neutralizing Antibodies Targeting BK Polyomavirus: Clinical Importance and Therapeutic Potential for Kidney Transplant Recipients.
    J Am Soc Nephrol. 2024;35:1425-1433.
    >> Share

    September 2024
  24. WILHELM M, Geng A, Schaub S, Hirsch HH, et al
    Posoleucel for BK Polyomavirus in Kidney Transplant Recipients.
    J Am Soc Nephrol. 2024 Sep 20. doi: 10.1681/ASN.0000000000000500.
    >> Share

  25. KIMMEL PL, Fwu CW, Nolin TD, Schulman IH, et al
    Opioid Prescriptions for US Patients Undergoing Long-Term Dialysis or with Kidney Transplant from 2011 to 2020.
    J Am Soc Nephrol. 2024 Sep 3. doi: 10.1681/ASN.0000000000000478.
    >> Share

  26. PERCUDANI R, Capelli C, Sassi G, Mori G, et al
    Evolutionary Differences in Uric Acid Metabolism Inform about the Risks of Pig-to-Human Kidney Transplant.
    J Am Soc Nephrol. 2024;35:1281-1283.
    >> Share

    August 2024
  27. CHAO CT
    The Role of Malnutrition and Psychiatric Illnesses in Olfactory Dysfunction Post-Kidney Transplantation.
    J Am Soc Nephrol. 2024 Aug 27. doi: 10.1681/ASN.0000000000000482.
    >> Share

  28. GUPTA A
    Authors' Reply: The Role of Malnutrition and Psychiatric Illnesses in Olfactory Dysfunction Post-Kidney Transplantation.
    J Am Soc Nephrol. 2024 Aug 27. doi: 10.1681/ASN.0000000000000483.
    >> Share

  29. MANNON RB, Vincenti F
    Poised for Innovation: Considerations for End Points for New Drug Development in Kidney Transplantation.
    J Am Soc Nephrol. 2024 Aug 5. doi: 10.1681/ASN.0000000000000475.
    >> Share

  30. AL AMMARY F, Adeyemo S, Lentine KL, Muzaale AD, et al
    Evolution of Biologically Related Living Kidney Donation in the United States from 1988 to 2022.
    J Am Soc Nephrol. 2024;35:1104-1106.
    >> Share

  31. KNOERS NVAM, van Eerde AM
    The Role of Genetic Testing in Adult CKD.
    J Am Soc Nephrol. 2024;35:1107-1118.
    >> Share

    July 2024
  32. PAJEWSKI NM, Beddhu S, Bress AP, Chang TI, et al
    The Legacy Effect of Intensive versus Standard Blood Pressure Control on the Incidence of Dialysis or Kidney Transplantation.
    J Am Soc Nephrol. 2024 Jul 30. doi: 10.1681/ASN.0000000000000459.
    >> Share

  33. GUPTA A, Holloway P, Young K, Villwock J, et al
    Changes in Olfactory and Cognitive Function after Kidney Transplantation.
    J Am Soc Nephrol. 2024 Jul 9. doi: 10.1681/ASN.0000000000000456.
    >> Share

  34. HELLE F, Aubry A, Morel V, Descamps V, et al
    Neutralizing Antibodies Targeting BK Polyomavirus: Clinical Importance and Therapeutic Potential for Kidney Transplant Recipients.
    J Am Soc Nephrol. 2024 Jul 9. doi: 10.1681/ASN.0000000000000457.
    >> Share

  35. PATZER RE
    Bridging Racial Disparities in Access to Kidney Transplantation in the United States: Glass Part-Empty or Part-Full?
    J Am Soc Nephrol. 2024;35:959-961.
    >> Share

    May 2024
  36. STOCK P, Rickert CG
    Consent for High-Kidney Donor Profile Index Kidneys: The Responsibility of Transplant Centers to Get it Right.
    J Am Soc Nephrol. 2024;35:528-529.
    >> Share

  37. SCHOLD JD, Conzen KD, Cooper J, Arrigain S, et al
    Quantifying the Effect of Consent for High-Kidney Donor Profile Index Deceased Donor Transplants in the United States.
    J Am Soc Nephrol. 2024;35:630-641.
    >> Share

  38. KING KL, Yu M, Huml AM, Schold JD, et al
    Allocation and Utilization Patterns of Deceased Donor Kidneys for Preemptive Transplantation in the United States.
    J Am Soc Nephrol. 2024;35:642-645.
    >> Share

    April 2024
  39. VAULET T, Callemeyn J, Lamarthee B, Antoranz A, et al
    The Clinical Relevance of the Infiltrating Immune Cell Composition in Kidney Transplant Rejection.
    J Am Soc Nephrol. 2024 Apr 19. doi: 10.1681/ASN.0000000000000350.
    >> Share

  40. STEINER RW
    Equity in Preemptive Kidney Transplantation: The Case for Caution.
    J Am Soc Nephrol. 2024 Apr 8. doi: 10.1681/ASN.0000000000000347.
    >> Share

    March 2024
  41. CHANDRAKER A, Regmi A, Gohh R, Sharma A, et al
    Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
    J Am Soc Nephrol. 2024 Mar 12. doi: 10.1681/ASN.0000000000000329.
    >> Share

  42. LAN JH
    Assessment of Novel Therapeutics to Improve Access to Transplantation for Highly Sensitized Patients in a Shifting Clinical Landscape.
    J Am Soc Nephrol. 2024;35:259-260.
    >> Share

    January 2024
  43. ADLER JT, Kuk AE, Cron DC, Parast L, et al
    Insurance Transitions from Employer-Based Insurance to Medicare and Waitlisting for Kidney Transplantation: Placing Marietta v. DaVita in Context.
    J Am Soc Nephrol. 2024 Jan 15. doi: 10.1681/ASN.0000000000000298.
    >> Share

  44. BAE S, McAdams-DeMarco MA
    Authors' Reply: Lipid Management and Interactions with Immunosuppressants in Kidney Transplant Patients: Some Opinions and Prospects.
    J Am Soc Nephrol. 2024;35:130.
    >> Share

  45. LI Y, Luo F, Gao Q, Su L, et al
    Lipid Management and Interactions with Immunosuppressants in Patients Undergoing Kidney Transplant: Opinions and Prospects.
    J Am Soc Nephrol. 2024;35:129.
    >> Share

    December 2023
  46. VINCENTI F, Bestard O, Brar A, Cruzado JM, et al
    Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant.
    J Am Soc Nephrol. 2023 Dec 26. doi: 10.1681/ASN.0000000000000287.
    >> Share

  47. HUSAIN SA
    Recentering Accountability for Disparities in Kidney Transplant Access.
    J Am Soc Nephrol. 2023 Dec 12. doi: 10.1681/ASN.0000000000000290.
    >> Share

  48. RAYNAUD M, Al-Awadhi S, Louis K, Zhang H, et al
    Prognostic Biomarkers in Kidney Transplantation: a Systematic Review and Critical Appraisal.
    J Am Soc Nephrol. 2023 Dec 6. doi: 10.1681/ASN.0000000000000260.
    >> Share

  49. RIZZOLO K, Cervantes L, Wilhalme H, Vasilyev A, et al
    Differences in Outcomes by Place of Origin among Hispanic Patients with Kidney Failure.
    J Am Soc Nephrol. 2023;34:2013-2023.
    >> Share

    October 2023
  50. SCHOLD JD, Huml AM, Husain SA, Mohan S, et al
    Why the National Academies Got it Wrong about Changing Preemptive Listing Priority for Kidney Transplantation.
    J Am Soc Nephrol. 2023;34:1615-1617.
    >> Share

  51. GREGORY AV, Denic A, Moustafa A, Dasaraju PG, et al
    The Number and Size of Individual Kidney Medullary Pyramids is Associated with Clinical Characteristics, Kidney Biopsy Findings, and CKD Outcomes among Kidney Donors.
    J Am Soc Nephrol. 2023;34:1752-1763.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016